165 Results for "

programmed cell death

" in MedChemExpress (MCE) Product Catalog:
Products (165)

165 Results for "programmed cell death" in MCE Product Catalog:

Cat. No.: HY-P2780
CAS No.: 9047-22-7
Research Areas:  

Others Cancer

Cathepsin B, Bovine spleen is a cysteine protease and is involved in multiple kinds of programmed cell death (including apoptosis, pyroptosis, ferroptosis, necroptosis, and autophagic cell death) .
loading...
    loading...
Cat. No.: HY-P99618
CAS No.: 2377419-89-9
Synonyms: IBI-315; BH2950

Target:  

EGFR PD-1/PD-L1

Research Areas:  

Cancer

Fidasimtamab is a bispecific antibody targeting human epidermal growth factor receptor 2 (Her2) and programmed death protein 1 (PD-1), with a Ka of 3.55e-10 M for human Her2 and a Ka of 1.17e-9 M for human PD-1. Fidasimtamab cross-links Her2-positive tumor cells with PD-1-positive T cells to form immune synapses, blocks PD-1-ligand interactions, preserves antibody-dependent cellular cytotoxicity, induces gasdermin B (GSDMB)-mediated pyroptosis, and activates T cells. Fidasimtamab is applicable to relevant research on Her2-positive gastric cancer .
loading...
    loading...
Cat. No.: HY-P99480
CAS No.: 1918149-01-5
Synonyms: M7824; MSB0011359C

Target:  

TGF-β Receptor

Research Areas:  

Cancer

Bintrafusp alfa (M 7824) is a first-in-class bifunctional fusion protein composed of the extracellular domain of TGF-βRII fused to a human IgG1 mAb blocking programmed cell death ligand. Bintrafusp alfa can be used for the research of cancer .
loading...
    loading...
Cat. No.: HY-P99203
CAS No.: 1801342-60-8
Synonyms: REGN-2810; SAR-439684

Target:  

PD-1/PD-L1

Research Areas:  

Cancer

Cemiplimab (Anti-Human PD-1) is a high-affinity programmed death receptor-1 (PD-1) monoclonal IgG4 antibody that blocks PD-1/PD-L1-mediated T-cell suppression. Cemiplimab is commonly used in squamous cell skin cancer research .
loading...
    loading...
Cat. No.: HY-P99473
CAS No.: 1987854-08-9
Synonyms: BI-505

Target:  

Integrin

Research Areas:  

Cancer

Bersanlimab (BI-505) is a fully human monoclonal antibody that targets intercellular adhesion molecule-1 (ICAM-1 or CD54). Bersanlimab has anticancer effects .
loading...
    loading...
Cat. No.: HY-P99114
CAS No.: 2256084-03-2

Target:  

PD-1/PD-L1

Research Areas:  

Cancer

Sugemalimab is a fully human, full length, anti-programmed death ligand 1 (PD-L1) immunoglobulin G4 (IgG4) monoclonal antibody (mAb). Sugemalimab shows anticancer activities and can be used for non-small cell lung cancer research .
loading...
    loading...
Cat. No.: HY-P10439
CAS No.: 2349354-64-7
Target:  

PD-1/PD-L1

Research Areas:  

Inflammation/Immunology Cancer

CVRARTR is a programmed cell death ligand-1 (PD-L1) antagonist with a KD of 281 nM. CVRARTR induces the internalization of PD-L1 and downregulates PD-L1 on the cell surface. CVRARTR restores cytokine secretion and T cell proliferation in cell CT26. CVRARTR exhibits antitumor efficacy against in CT26 homograft mouse model. CVRARTR can be used in melanoma research .
loading...
    loading...
Cat. No.: HY-P99941
CAS No.: 2079108-44-2
Synonyms: INCMGA-00012; MGA-012

Target:  

PD-1/PD-L1

Research Areas:  

Cancer

Retifanlimab is an anti-programmed cell death protein 1 (anti-PD-1) monoclonal antibody (mAb). Retifanlimab can be used for the research of gastroesophageal adenocarcinoma (GEA) .
loading...
    loading...
Cat. No.: HY-101058A
Purity:  95.11%
Target:  

PD-1/PD-L1

Research Areas:  

Inflammation/Immunology Cancer

PD1-PDL1-IN 1 TFA (compound 16) is a potent programmed cell death 1 (PD-1) inhibitor. PD1-PDL1-IN 1 TFA is useful as immune modulator .
loading...
    loading...
Cat. No.: HY-101097
CAS No.: 1673560-66-1
Purity:  99.57%
Target:  

PD-1/PD-L1

Research Areas:  

Cancer

PD-1-IN-17 is a programmed cell death-1 (PD-1) inhibitor extracted from patent WO2015033301A1, Compound 12, inhibits 92% splenocyte proliferation at 100 nM .
loading...
    loading...
Cat. No.: HY-P99938
CAS No.: 2403647-03-8
Synonyms: HX008

Target:  

PD-1/PD-L1

Research Areas:  

Cancer

Pucotenlimab (HX008) is a humanized immunoglobulin G4 (IgG4) anti programmed cell death protein 1 (anti-PD-1) monoclonal antibody. Pucotenlimab can be used for the research of tumor .
loading...
    loading...
Cat. No.: HY-152944
CAS No.: 871340-88-4
Purity:  99.70%
Research Areas:  

Cancer

S6K1-IN-DG2 (Compound 66) is a p70S6K inhibitor (IC50: < 100 nM) .
loading...
    loading...
Cat. No.: HY-128605
CAS No.: 2349372-98-9
Purity:  98.99%
Target:  

PD-1/PD-L1

Research Areas:  

Cancer

PD-1-IN-22 is a potent programmed cell death-1 (PD-1)/programmed cell death-ligand 1 (PD-L1) interaction inhibitor with an IC50 of 92.3 nM .
loading...
    loading...
Cat. No.: HY-P10950
CAS No.: 1931111-41-9
Target:  

PD-1/PD-L1

Research Areas:  

Inflammation/Immunology Cancer

PD-L1 inhibitory peptide is an inhibitor peptide targeting programmed cell death ligand 1 (PD-L1). PD-L1 inhibitory peptide binds to PD-L1, relieving immunosuppression and restoring the antitumor activity of T cells. PD-L1 inhibitory peptide is promising for research of cancers .
loading...
    loading...
Cat. No.: HY-149393
CAS No.: 3052303-53-1
Purity:  95.98%
Research Areas:  

Cancer

RIPK3-IN-3 (compound 20) is a selective inhibitor of RIP kinase RIPK3 (IC50=10 nM). RIPK3 mediates the phosphorylation of Mixed Lineage Kinase (MLKL) and causes necroptosis, while RIPK3-IN-3 inhibits p-MLKL oligomerization and thereby inhibits necroptosis. RIPK3-IN-3 also downregulates CXCL5 secretion and inhibits AsPC-1 cell migration and invasion .
loading...
    loading...
Cat. No.: HY-P10370
CAS No.: 721397-24-6
Target:  

Bacterial Apoptosis

Research Areas:  

Infection Cancer

d-(KLAKLAK)2, as an antibacterial and anti-tumor polypeptide, is a representative of the antimicrobial peptide group, and also has good anticancer properties. d-(KLAKLAK)2 is able to kill bacteria by damaging their cell membranes, causing cell contents to leak out. d-(KLAKLAK)2 can also inhibit tumor cell proliferation by causing mitochondrial swelling and mitochondrial membrane destruction, triggering apoptosis (programmed cell death) .
loading...
    loading...
Cat. No.: HY-P991122
CAS No.: 3037124-22-1
Synonyms: ONO-4685

Target:  

PD-1/PD-L1 CD3

Research Areas:  

Inflammation/Immunology Cancer

Besufetamig is a bispecific antibody targeting programmed cell death 1 (PD-1) and CD3ε chain. Besufetamig modulates the activity of immune cells, exerting immunosuppressive and antineoplastic activities. Besufetamig is promising for research of cancers .
loading...
    loading...
Cat. No.: HY-34765
CAS No.: 7341-96-0
Propiolamide is a monooxygenase (MMO) system activator and glutathione peroxidase 4 (GPX4) inhibitor. Propiolamide induces ROS production through interaction with the MMO system. Propiolamide promotes the accumulation of intracellular cytotoxic lipid peroxides and induces ferroptosis. Propiolamide induces programmed cell death via the apoptosis pathway. Propiolamide can be used in cancer research .
loading...
    loading...
Cat. No.: HY-101058
CAS No.: 2005454-12-4
Target:  

PD-1/PD-L1

Research Areas:  

Inflammation/Immunology

PD1-PDL1-IN 1 (compound 16) is a potent programmed cell death 1 (PD-1) inhibitor. PD1-PDL1-IN 1 is useful as immune modulator .
loading...
    loading...
Cat. No.: HY-151066
CAS No.: 2447065-99-6
Target:  

PD-1/PD-L1

Research Areas:  

Cancer

BMS-1233 is an orally active inhibitor for programmed cell death-ligand 1 (PD-L1), with IC50 of 14.5 nM. BMS-1233 promotes cell death of HepG2 in a Jurkat T cell and HepG2 cell co-culture model, exhibits antitumor activity against melanoma in mouse model .
loading...
    loading...